The medication, suzetrigine (JOURNAVX (R) ), was FDA-approved in January 2025 and became available at HSS in April 2025. It is the first non-opioid pain reliever released in more than 25 years.

Orthopedic surgery patients responded well to a new nonopioid pain reliever, according to a new study from New York ...

When experiencing pain after surgery, patients are often prescribed powerful opioid pain relievers. These medications are addictive, and patients who have never abused drugs can become dependent on ...

The number of times this week I have heard people talk excitedly about their upcoming back surgery has left me genuinely disheartened. Not because surgery never has a place - but because it highlights ...

DENVER--(BUSINESS WIRE)--Spine surgeons at Hospital for Special Surgery (HSS) reported promising findings for adolescent athletes suffering from pars fracture, a common cause of adolescent back pain ...

PHOENIX — A growing medical trend is helping cure something 80% of Americans will experience in their lifetime – back pain, which is a leading cause of disability, work loss, and doctor visits. Donna ...